• Home
  • News
  • Portfolio News
  • Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale

Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale

22Jul

Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale

Portfolio News

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, today announced a commercial agreement with Seppic S.A., a supplier of specialty healthcare ingredients, for the supply of adjuvant for use in Akston’s COVID-19 Fc fusion protein vaccine candidate, AKS-452. Read more >>

Share this post

Related Posts

30Sep

XYLYX BIO launches specialized contract R&D services that increase predictiveness in antifibrotic drug discovery

Xylyx Bio, a leader in advanced disease models for drug discovery, today announced the launch of specialized contract R&D services... read more
05Apr

Siamab Therapeutics Presents New Preclinical Data for Its Novel Anti-STn Antibodies, Antibody-Drug Conjugates, and Anti-STn Bispecific Antibodies at the AACR Annual Meeting 2017

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced the presentation of two posters featuring new preclinical... read more
19May

The Evolution of Premium Canned Wine

Canned wine isn’t just found on grocery store shelves and at outdoor festivals these days...An increasing awareness of sustainability and... read more
02Sep

Corbus Pharmaceuticals to Host Fireside Chat on Dermatomyositis with Expert Physician and Researcher, Victoria Werth, MD

Corbus Pharmaceuticals Holdings, Inc.(NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious inflammatory... read more
11Sep

Rapid Lyme test developed at Cornell could be ‘major breakthrough’ in treatment

The test would quickly confirm the presence of the bacteria that causes Lyme, rather than waiting for weeks for a... read more
18Apr

Legally Blind Teen Can See Again, And Is Helping Visually Impaired Children See their Mothers For The First Time this Mother’s Day

Joel Gomez, a 14-year-old boy born with legal blindness, can now see thanks to eSight, a breakthrough pair of electronic... read more
19Sep

DetraPel: Advanced Materials Company Secures $7.6 Million

DetraPel – the advanced materials company that manufactures sustainable coatings – recently announced the completion of its $7.6 million Series... read more
08Sep

Regroup Mass Notification Readies Temporary Network to Aid Organizations Affected by Hurricane Irma

Regroup Mass Notification announced that it is donating access to its powerful mass communication platform to organizations needing to communicate... read more
17Aug

Study Indicates Bionic Knee Brace Designed for Osteoarthritis Reduces Joint Load Across the Entire Knee Offering a New Non-Surgical Option for Patients

A recent study by researchers at the University of New Brunswick (UNB) indicates that tricompartment unloader knee braces are an... read more
31Jul

Hope in sight for one local family

While there is no medical cure for Stargardt’s disease, there are technologies available that are designed to make living with... read more